首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1845878

2024-2031 年血管成形术用气球和支架市场：按产品、适应症、最终用户和地区划分

Angioplasty Balloons And Stents Market By Product (Stents, Balloons), Indication (Coronary Artery Diseases, Peripheral Artery Diseases), End-User (Hospitals, Ambulatory Surgical Centers, Cath Labs), And Region For 2024-2031

出版日期: 2025年09月21日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

血管成形术用气球和支架市场评估 - 2024-2031

微创手术的进步和心血管疾病发病率的上升正在推动血管成形术球囊和支架市场的发展。根据 Verified Market Research 分析师预测，2024 年血管成形术用气球和支架市场规模约 67.7 亿美元，预测期内将达到 97.5 亿美元。

经经皮冠状动脉介入治疗的增加、技术进步提高了产品功效以及老龄化人口更容易患心血管疾病是推动血管成形术用气球和支架市场强劲增长的因素，预计从 2024 年到 2031 年，该市场的复合年增长率将达到 4.67%。

血管成形术用气球和支架市场定义/概述

血管成形术用气球和支架是用于治疗血流受限或阻塞的医疗设备，主要用于治疗心臟冠状动脉血流受限或阻塞。血管成形术用气球是一种可充气装置，当插入受限的动脉时，球囊会扩张以拓宽导管并恢復血流。而支架是一种小型网状管，通常由金属或聚合物製成，在球囊血管成形术过程中插入动脉。支架起到支撑作用，保持动脉畅通，防止再次狭窄。

此外，这些装置通常用于治疗冠状动脉疾病 (CAD)。冠状动脉疾病是指动脉中积聚的脂肪沉积物（称为斑块）导致心肌血流减少所引发的疾病。透过恢復正常的心臟血流，血管成形术用气球和支架可以缓解冠状动脉疾病的症状，例如胸痛（心绞痛），并降低心臟病发作的风险。它们也用于治疗周边动脉疾病( PAD)。週边动脉疾病是指腿部、手部、足部和身体其他部位的动脉变窄或阻塞，导致腿部不适和麻木等症状。

推动血管成形术用气球和支架市场成长的关键因素是什么？

全球心血管疾病盛行率的上升是血管成形术用气球和支架市场的主要驱动力。随着越来越多的人被诊断出患有冠状动脉疾病等心臟相关疾病，对血管成形术等微创手术的需求也日益增长。这项技术使用球囊和支架来打通受限或阻塞的动脉，增加流向心臟的血流量。

血管成形术球囊和支架的技术已取得显着进步，使其更加安全、有效和可靠。例如，药物释放型支架 (DES) 的发明代表了一项重大进步，它能够缓慢释放药物，防止动脉再次阻塞。此外，生物可吸收血管支架的引入以及球囊导管技术的进步改善了患者的治疗效果，并刺激了市场扩张。

此外，全球人口结构正在经历老化。由于心血管系统的自然老化、长期风险因素的累积以及高血压、糖尿病和肥胖等併发症的存在，老年人更容易患上心血管疾病。这些人口趋势导致需要血管成形术治疗的患者数量增加，从而推动了对球囊和支架的需求。

影响市场成长的挑战有哪些？

儘管技术不断发展，血管成形术和支架植入置入术仍充满风险和潜在併发症，例如血栓、动脉狭窄（血管再阻塞）、导管插入部位出血，以及在极少数情况下发生的动脉破裂。这些风险使患者不愿接受这些手术，并可能使製造商和医疗保健提供者面临法律和财务后果，从而限制市场扩张。

此外，心血管疾病管理的替代治疗方法和技术也为血管成形术用气球和支架市场带来了压力。冠状动脉绕道手术手术 (CABG) 等外科手术为一些患有严重冠状动脉疾病的患者提供了更持久的解决方案。此外，针对动脉阻塞根本原因的新药和非侵入性治疗方法的开发与血管成形术和支架置入术构成了竞争。这些治疗方案因患者病情和医疗专业人员的建议而异，这阻碍了血管成形术用气球和支架市场的扩张。

Advancements in minimally invasive procedures, as well as an increasing frequency of cardiovascular disorders, are propelling the Angioplasty Balloons And Stents Market. According to the analyst from Verified Market Research, the Angioplasty Balloons And Stents Market is estimated to reach a valuation of USD 9.75 Billion over the forecast subjugating around USD 6.77 Billion valued in 2024.

Increasing use of percutaneous coronary intervention procedures, advancements in technology that improve product efficacy, and an aging population that is more vulnerable to cardiovascular diseases are all contributing factors to the Angioplasty Balloons And Stents Market's strong growth. This enables the market to grow at a CAGR of 4.67% from 2024 to 2031.

Angioplasty Balloons And Stents Market: Definition/ Overview

Angioplasty Balloons and stents are medical devices that treat restricted or obstructed blood channels, primarily in the coronary arteries of the heart. Angioplasty balloons are inflatable devices that, once put into a restricted artery, expand to enlarge the conduit and restore blood flow. Stents, on the other hand, are small mesh tubes usually made of metal or polymer that are inserted into the artery during balloon angioplasty. They operate as scaffolding, keeping the artery open and preventing it from narrowing again.

Furthermore, these devices are generally used to treat coronary artery disease (CAD), which develops when fatty deposits known as plaque accumulate inside the arteries, reducing blood flow to the heart muscle. Angioplasty balloons and stents assist relieve CAD symptoms, such as chest pain (angina), and lower the risk of a heart attack by restoring appropriate blood flow to the heart. They are also used to treat peripheral artery disease (PAD), which occurs when arteries in the legs, limbs, or other regions of the body narrow or get clogged, causing symptoms such as leg discomfort or numbness.

What are the Key Factors Driving the Growth of the Angioplasty Balloons And Stents Market?

The rising global incidence of cardiovascular illnesses is a major driver of the Angioplasty Balloons And Stents Market. The need for minimally invasive surgeries like angioplasty is rising as more people receive diagnoses for heart-related disorders, such as coronary artery disease. This technique employs balloons and stents to widen restricted or obstructed arteries, increasing blood flow to the heart.

The technology behind angioplasty balloons and stents has advanced significantly, making them safer, more effective, and more reliable. For example, the invention of drug-eluting stents (DES) that slowly release medication to keep the artery from becoming blocked again has resulted in tremendous progress. Also, the introduction of bioresorbable vascular scaffolds and advances in balloon catheter technology help to improve patient outcomes and fuel market expansion.

Furthermore, the world is experiencing a demographic shift toward an elderly population. Older people are more likely to acquire cardiovascular disorders as a result of natural aging of the cardiovascular system, the accumulation of risk factors over time, and the existence of comorbid conditions such as hypertension, diabetes, and obesity. This demographic trend increases the number of patients who require angioplasty treatments, which drives up demand for balloons and stents.

What are the Challenges Influencing the Growth of the Market?

Despite technological developments, angioplasty and stent implantation operations continue to pose risks and potential complications, including blood clots, arterial narrowing (restenosis), bleeding at the catheter insertion site, and, in rare circumstances, artery rupture. These hazards prevent patients from undergoing these operations and might result in legal and financial consequences for manufacturers and healthcare providers, thereby limiting market expansion.

Furthermore, alternative treatment procedures and technology for cardiovascular disease management are putting pressure on the market for angioplasty balloons and stents. Surgical procedures, such as coronary artery bypass grafting (CABG), provide a more permanent solution for some patients with severe coronary artery disease. Also, the development of new medications and non-invasive treatments that address the underlying causes of artery blockages competes with angioplasty and stenting operations. The choice for these alternatives, which vary based on the patient's condition and the recommendation of their healthcare professional, poses a barrier to the market expansion of angioplasty balloons and stents.

Category-Wise Acumens

How is the Demand for Stents Increasing in the Market?

According to VMR analysis, the stents segment is estimated to hold the largest market share during the forecast period. Stents, particularly drug-eluting stents (DES), have evolved dramatically over time. These stents not only keep the artery open, but they also release medication over time to keep it from being blocked again (restenosis). This dual function considerably improves patient outcomes and reduces the need for additional operations. Continuous innovation in stent technology, such as the creation of bioresorbable stents and advances in the materials and coatings utilized, improves their efficacy and safety profile, making them the preferred treatment option for coronary artery disease.

Stents are used in a wider spectrum of cardiovascular diseases than angioplasty balloons. While balloons are primarily used to widen the artery, stents give structural support to keep it from narrowing further. This means that stents can be used not only for coronary artery disease but also for peripheral artery disease and other vascular interventions, boosting their utility and adoption in a broader range of cardiovascular treatments.

Furthermore, many healthcare systems have more favorable payment policies for stent implantation treatments due to their demonstrated efficacy and long-term advantages in controlling coronary artery disease. Healthcare providers and patients frequently prefer treatments that are covered by insurance or have higher reimbursement rates, contributing to the stents segment's market dominance. Also, as healthcare systems and insurance companies understand the cost-effectiveness of stent implantations in minimizing the need for future cardiovascular treatments, the use of stents is increasing.

How Does Coronary Artery Disease (CAD) Support the Growing Demand in the Market?

The coronary artery diseases (CAD) segment is estimated to exhibit the highest growth within the Angioplasty Balloons And Stents Market during the forecast period. CAD is a primary cause of morbidity and mortality worldwide, affecting a large proportion of the adult population. Sedentary lifestyles, bad diets, smoking, hypertension, diabetes, and high cholesterol all contribute to the condition's prevalence. The high global incidence of CAD creates a significant demand for angioplasty procedures and the use of balloons and stents as major therapies to restore blood flow in constricted or blocked coronary arteries.

There has been a huge increase in awareness of heart disease and its symptoms, which has resulted in higher CAD diagnostic rates. Advances in diagnostic tools, such as coronary angiograms, CT scans, and MRIs, have made it simpler to detect CAD early on. Early detection increases the possibility of patients receiving angioplasty operations, driving up demand for coronary stents and balloons.

Furthermore, the segment has seen tremendous technological breakthroughs, such as the introduction of drug-eluting stents, bioresorbable stents, and cutting-edge balloon catheter technologies. These developments have increased the safety, efficacy, and patient outcomes of angioplasty operations for CAD. Modern coronary stents and balloons are the recommended treatment for CAD due to their improved performance and lower complication rates, which contributes to their leading market position.

Country/Region-wise Acumens

How is the High Prevalence of Cardiovascular Diseases Driving the Market in North America?

According to VMR analyst, North America is estimated to dominate the Angioplasty Balloons And Stents Market during the forecast period. Sedentary lifestyles, obesity, diabetes, and smoking all contribute to the region's high prevalence of cardiovascular disease. This large patient population needs the use of efficient treatment options, such as angioplasty with balloons and stents, to manage and treat coronary and peripheral artery disorders, hence driving the market.

North America, particularly the United States, has one of the world's most advanced healthcare infrastructures. This includes extensive access to advanced medical facilities, highly skilled healthcare professionals, and cutting-edge medical technology. A strong healthcare system promotes early detection, treatment, and management of cardiovascular disorders, such as coronary and peripheral artery disease, increasing demand for angioplasty balloons and stents.

Furthermore, North America, especially the United States, offers advantageous payment regulations for cardiovascular operations, making treatments such as angioplasty more affordable to a wider range of the population. When combined with the region's good economic conditions, these factors contribute to increased healthcare spending, particularly modern medical equipment for cardiovascular procedures. Furthermore, the presence of major medical device makers in the region, together with significant R&D investments, drives market expansion.

What are the Main Drivers of the Angioplasty Balloons And Stents Market in Asia Pacific?

The Asia Pacific region is estimated to exhibit the highest growth within the market during the forecast period. The Asia Pacific region has the world's largest population, including a sizable senior population that is more susceptible to cardiovascular diseases (CVDs). Japan has one of the largest numbers of aged people in the world, while China and India are seeing substantial rises in their aging populations. This generational shift raises the incidence of coronary and peripheral arterial disorders, driving up demand for angioplasty operations and associated devices.

Many Asia Pacific countries are making significant changes to their healthcare systems, including expanding healthcare facilities and services to rural and underserved communities. Increased healthcare spending, combined with government attempts to improve healthcare infrastructure and accessibility, has made modern medical treatments, such as angioplasty with balloons and stents, more accessible to a wider range of patients.

Furthermore, the region has undergone tremendous economic expansion in recent decades, resulting in increased healthcare spending by both governments and people. Growing health awareness, higher disposable incomes, and the inclusion of modern medical procedures in insurance coverages have made Asian Pacific communities more proactive in seeking cardiovascular disease therapy. Also, the existence of growing economies such as China and India helps to build a middle class that can afford more advanced healthcare alternatives.

Competitive Landscape

The competitive landscape of the Angioplasty Balloons And Stents Market is characterized by fierce competition caused by a variety of factors. Also, market participants are focusing on extending their geographical presence to enter emerging countries and capitalize on the growing demand for minimally invasive cardiovascular procedures.

Some of the prominent players operating in the Angioplasty Balloons And Stents Market include:

Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cook Medical, Biosensors International Group, MicroPort Scientific Corporation, Terumo Corporation, Stentys SA, Biotronik, Becton, Dickinson and Company, Cordis Corp, AngioDynamics, Braun Melsungen AG, Philips, Oscor Inc., Royal DSM N.V., Spectranetics Corp.

Latest Developments

In April 2024, Abbott reported positive long-term data from the ABSORB absorbable scaffold platform at EuroPCR 2024.

In March 2024, Medtronic announced the U.S. FDA approval of the Resolute Onyx DES with EverFlex Technology for the treatment of coronary artery disease.

In February 2024, Boston Scientific announced the global launch of EXILIFE DES*, a next-generation drug-eluting stent for coronary artery disease.

1 INTRODUCTION OF GLOBAL ANGIOPLASTY BALLOONS AND STENTS MARKET

1.1 Introduction of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ANGIOPLASTY BALLOONS AND STENTS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ANGIOPLASTY BALLOONS AND STENTS MARKET, BY PRODUCT

5.1 Overview
5.2 Stents
5.3 Balloons

6 GLOBAL ANGIOPLASTY BALLOONS AND STENTS MARKET, BY END-USER

6.1 Overview
6.2 Hospitals
6.3 Ambulatory Surgical Centers
6.4 Cath Labs
6.5 Others

7 GLOBAL ANGIOPLASTY BALLOONS AND STENTS MARKET, BY INDICATION

7.1 Overview
7.2 Coronary Artery Diseases
7.3 Peripheral Artery Diseases

8 GLOBAL ANGIOPLASTY BALLOONS AND STENTS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East

9 GLOBAL ANGIOPLASTY BALLOONS AND STENTS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Medtronic plc
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Abbott Laboratories
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Boston Scientific Corporation
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Cook Medical
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Biosensors International Group
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 MicroPort Scientific Corporation
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Terumo Corporation
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Stentys SA
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Biotronik
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Becton
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments

11 Appendix

11.1 Related Research

02-2729-4219

+886-2-2729-4219

License/价格

2024-2031 年血管成形术用气球和支架市场：按产品、适应症、最终用户和地区划分

Angioplasty Balloons And Stents Market By Product (Stents, Balloons), Indication (Coronary Artery Diseases, Peripheral Artery Diseases), End-User (Hospitals, Ambulatory Surgical Centers, Cath Labs), And Region For 2024-2031

血管成形术用气球和支架市场评估 - 2024-2031

推动血管成形术用气球和支架市场成长的关键因素是什么？

影响市场成长的挑战有哪些？

目录

第一章全球血管成形术用气球和支架市场简介

第二章执行摘要

第三章：已验证的市场研究调查方法

第四章血管成形术用气球的全球市场展望

第五章全球血管成形术用气球及支架市场（依产品）

第六章全球血管成形术用气球和支架市场（依最终用户）

第七章全球血管成形术用气球和支架市场（按适应症）

第八章全球血管成形术用气球和支架市场（按地区）

第九章全球血管成形术用气球和支架市场的竞争格局

第十章：公司简介

第十一章 附录

Angioplasty Balloons And Stents Market Valuation - 2024-2031